Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations-Reference-Cited by-同舟云学术

Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

Published:2020-09-03 Issue:10 Volume:383 Page:931-943
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Paik Paul K.¹,Felip Enriqueta¹,Veillon Remi¹,Sakai Hiroshi¹,Cortot Alexis B.¹,Garassino Marina C.¹,Mazieres Julien¹,Viteri Santiago¹,Senellart Helene¹,Van Meerbeeck Jan¹,Raskin Jo¹,Reinmuth Niels¹,Conte Pierfranco¹,Kowalski Dariusz¹,Cho Byoung Chul¹,Patel Jyoti D.¹,Horn Leora¹,Griesinger Frank¹,Han Ji-Youn¹,Kim Young-Chul¹^ORCID,Chang Gee-Chen¹,Tsai Chen-Liang¹,Yang James C.-H.¹,Chen Yuh-Min¹,Smit Egbert F.¹,van der Wekken Anthonie J.¹,Kato Terufumi¹,Juraeva Dilafruz¹,Stroh Christopher¹,Bruns Rolf¹,Straub Josef¹,Johne Andreas¹,Scheele Jürgen¹,Heymach John V.¹,Le Xiuning¹

Affiliation:

1. From Memorial Sloan Kettering Cancer Center, New York (P.K.P.); the Oncology Department, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (E.F.), and Dr. Rosell Oncology Institute, Dexeus University Hospital, Quirónsalud Group (S.V.), Barcelona; Centre Hospitaliere Universitaire (CHU) Bordeaux, Service des Maladies Respiratoires, Bordeaux (R.V.), Université de Lille, CHU Lille, Thoracic Oncology Department, Centre National de la Recherche Scientifique, INSERM, Institut Pasteur de...

Funder

Merck KGaA, Darmstadt, Germany

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2004407

Cited by 581 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology;Lung Cancer;2024-10

2. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine;Life;2024-09-10

3. Tepotinib in a Patient With Advanced Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Undergoing Concomitant Hemodialysis for Renal Failure: A Case Report;CLIN LUNG CANCER;2024

4. Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer;CLIN LUNG CANCER;2024

5. Explainable machine learning prediction of edema adverse events in patients treated with tepotinib;Clinical and Translational Science;2024-09